Roche has revealed the data behind a positive phase 3 trial for its oral BTK inhibitor fenebrutinib in primary progressive multiple sclerosis (PPMS), revealing that it was at least as effective as its ...

Attorneys at Berger Kahn discuss the use of electronic employee monitoring and considerations regarding liability issues, such as the nature of the employment, the state where the employee works, and ...